UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Body fat composition impacts the hematologic toxicities and pharmacokinetics of doxorubicin in Asian breast cancer patients

Breast cancer research and treatment, 2014-02, Vol.144 (1), p.143-152

2014

Volltextzugriff (PDF)

Population Pharmacokinetics and Pharmacodynamics of Doxorubicin and Cyclophosphamide in Breast Cancer Patients : A Study by the EORTC-PAMM-NDDG

Clinical pharmacokinetics, 2007-01, Vol.46 (12), p.1051-1068

2007

Volltextzugriff (PDF)

Macrophage-cancer hybrid membrane-coated nanoparticles for targeting lung metastasis in breast cancer therapy

Journal of nanobiotechnology, 2020-06, Vol.18 (1), p.92-17, Article 92

2020

Volltextzugriff (PDF)

In vivo effect of oracin on doxorubicin reduction, biodistribution and efficacy in Ehrlich tumor bearing mice

Pharmacological reports, 2013, Vol.65 (2), p.445-452

2013

Volltextzugriff (PDF)

Chemotherapeutic Delivery from a Self-Assembling Peptide Nanofiber Hydrogel for the Management of Glioblastoma

Pharmaceutical research, 2018-08, Vol.35 (8), p.166-13, Article 166

2018

Volltextzugriff (PDF)

pH and redox dual-responsive nanoparticles based on disulfide-containing poly(β-amino ester) for combining chemotherapy and COX-2 inhibitor to overcome drug resistance in breast cancer

Journal of nanobiotechnology, 2019-10, Vol.17 (1), p.109-109, Article 109

2019

Volltextzugriff (PDF)

Novel Core-Interlayer-Shell DOX/ZnPc Co-loaded MSNs@ pH-Sensitive CaP@PEGylated Liposome for Enhanced Synergetic Chemo-Photodynamic Therapy

Pharmaceutical research, 2018-03, Vol.35 (3), p.57-12, Article 57

2018

Volltextzugriff (PDF)

Mechanistic physiology-based pharmacokinetic modeling to elucidate vincristine-induced peripheral neuropathy following treatment with novel kinase inhibitors

Cancer chemotherapy and pharmacology, 2021-09, Vol.88 (3), p.451-464

2021

Volltextzugriff (PDF)

Lipodox® (generic doxorubicin hydrochloride liposome injection): in vivo efficacy and bioequivalence versus Caelyx® (doxorubicin hydrochloride liposome injection) in human mammary carcinoma (MX-1) xenograft and syngeneic fibrosarcoma (WEHI 164) mouse models

BMC cancer, 2017-06, Vol.17 (1), p.405-405, Article 405

2017

Volltextzugriff (PDF)

PEGylated PAMAM Dendrimer-Doxorubicin Conjugates: In Vitro Evaluation and In Vivo Tumor Accumulation

Pharmaceutical research, 2010, Vol.27 (1), p.161-174

2010

Volltextzugriff (PDF)

Improving anti-cancer drug delivery performance of magnetic mesoporous silica nanocarriers for more efficient colorectal cancer therapy

Journal of nanobiotechnology, 2021-10, Vol.19 (1), p.314-314, Article 314

2021

Volltextzugriff (PDF)

Doxorubicin concentrations in bone tumour-relevant tissues after bolus and continuous infusion: a randomized porcine microdialysis study

Cancer chemotherapy and pharmacology, 2024-06, Vol.93 (6), p.555-564

2024

Volltextzugriff (PDF)

Rhamnolipid-coated W/O/W double emulsion nanoparticles for efficient delivery of doxorubicin/erlotinib and combination chemotherapy

Journal of nanobiotechnology, 2021-12, Vol.19 (1), p.411-411, Article 411

2021

Volltextzugriff (PDF)

Near-Infrared Light-Sensitive Liposomes for the Enhanced Photothermal Tumor Treatment by the Combination with Chemotherapy

Pharmaceutical research, 2014-03, Vol.31 (3), p.554-565

2014

Volltextzugriff (PDF)

Quantitative evaluation of liposomal doxorubicin and its metabolites in spheroids

Analytical and bioanalytical chemistry, 2019-11, Vol.411 (27), p.7087-7094

2019

Volltextzugriff (PDF)

Effects of quercetin on the bioavailability of doxorubicin in rats: Role of CYP3A4 and P-gp inhibition by quercetin

Archives of Pharmacal Research, 2011, 34(4), , pp.607-613

2011

Volltextzugriff (PDF)

Exploring the Spatial Drug Distribution Pattern of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC)

Annals of surgical oncology, 2016-04, Vol.23 (4), p.1220-1224

2016

Volltextzugriff (PDF)

A Microfluidic Perfusion Platform for In Vitro Analysis of Drug Pharmacokinetic-Pharmacodynamic (PK-PD) Relationships

The AAPS journal, 2020-03, Vol.22 (2), p.53, Article 53

2020

Volltextzugriff (PDF)

LRP1-mediated pH-sensitive polymersomes facilitate combination therapy of glioblastoma in vitro and in vivo

Journal of nanobiotechnology, 2021-01, Vol.19 (1), p.29-17, Article 29

2021

Volltextzugriff (PDF)

Ultrasmall nanostructured drug based pH-sensitive liposome for effective treatment of drug-resistant tumor

Journal of nanobiotechnology, 2019-11, Vol.17 (1), p.117-13, Article 117

2019

Volltextzugriff (PDF)

Bicontinuous Cubic Liquid Crystalline Nanoparticles for Oral Delivery of Doxorubicin: Implications on Bioavailability, Therapeutic Efficacy, and Cardiotoxicity

Pharmaceutical research, 2014-05, Vol.31 (5), p.1219-1238

2014

Volltextzugriff (PDF)

Pharmacokinetic study of aldoxorubicin in patients with solid tumors

Investigational new drugs, 2015-04, Vol.33 (2), p.341-348

2015

Volltextzugriff (PDF)

Enhanced Specificity and Drug Delivery in Tumors by cRGD - Anchoring Thermosensitive Liposomes

Pharmaceutical research, 2015-12, Vol.32 (12), p.3862-3876

2015

Volltextzugriff (PDF)

Distribution of the anticancer drugs doxorubicin, mitoxantrone and topotecan in tumors and normal tissues

Cancer chemotherapy and pharmacology, 2013-07, Vol.72 (1), p.127-138

2013

Volltextzugriff (PDF)

Factors affecting the pharmacokinetics of pegylated liposomal doxorubicin in patients

Cancer chemotherapy and pharmacology, 2012-01, Vol.69 (1), p.43-50

2012

Volltextzugriff (PDF)

1 – 25 von 562

Suche als RSS-Feed

Aktive Filter

KollektionSpringerLink Journals - AutoHoldings

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(547)
Mit Volltextzugriff
(542)

Publikationsform

Artikel
(562)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(509)
Life Sciences & Biomedicine
(481)
Doxorubicin - Pharmacokinetics
(387)
Humans
(376)
Pharmacology & Pharmacy
(343)
Doxorubicin
(276)
Oncology
(271)
Female
(257)
Biological And Medical Sciences
(256)
Medical Sciences
(253)
Doxorubicin - Administration & Dosage
(244)
Pharmacology. Drug Treatments
(239)
Animals
(234)
Antineoplastic Agents
(208)
Chemotherapy
(184)
Male
(174)
Pharmacokinetics
(164)
Antibiotics, Antineoplastic - Pharmacokinetics
(151)
Pharmacology/toxicology
(151)
Medicine
(120)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Body fat composition impacts the hematologic toxicities and pharmacokinetics of doxorubicin in Asian breast cancer patients

Population Pharmacokinetics and Pharmacodynamics of Doxorubicin and Cyclophosphamide in Breast Cancer Patients : A Study by the EORTC-PAMM-NDDG

Macrophage-cancer hybrid membrane-coated nanoparticles for targeting lung metastasis in breast cancer therapy

In vivo effect of oracin on doxorubicin reduction, biodistribution and efficacy in Ehrlich tumor bearing mice

Chemotherapeutic Delivery from a Self-Assembling Peptide Nanofiber Hydrogel for the Management of Glioblastoma

pH and redox dual-responsive nanoparticles based on disulfide-containing poly(β-amino ester) for combining chemotherapy and COX-2 inhibitor to overcome drug resistance in breast cancer

Novel Core-Interlayer-Shell DOX/ZnPc Co-loaded MSNs@ pH-Sensitive CaP@PEGylated Liposome for Enhanced Synergetic Chemo-Photodynamic Therapy

Mechanistic physiology-based pharmacokinetic modeling to elucidate vincristine-induced peripheral neuropathy following treatment with novel kinase inhibitors

Lipodox® (generic doxorubicin hydrochloride liposome injection): in vivo efficacy and bioequivalence versus Caelyx® (doxorubicin hydrochloride liposome injection) in human mammary carcinoma (MX-1) xenograft and syngeneic fibrosarcoma (WEHI 164) mouse models

PEGylated PAMAM Dendrimer-Doxorubicin Conjugates: In Vitro Evaluation and In Vivo Tumor Accumulation

Improving anti-cancer drug delivery performance of magnetic mesoporous silica nanocarriers for more efficient colorectal cancer therapy

Doxorubicin concentrations in bone tumour-relevant tissues after bolus and continuous infusion: a randomized porcine microdialysis study

Rhamnolipid-coated W/O/W double emulsion nanoparticles for efficient delivery of doxorubicin/erlotinib and combination chemotherapy

Near-Infrared Light-Sensitive Liposomes for the Enhanced Photothermal Tumor Treatment by the Combination with Chemotherapy

Quantitative evaluation of liposomal doxorubicin and its metabolites in spheroids

Effects of quercetin on the bioavailability of doxorubicin in rats: Role of CYP3A4 and P-gp inhibition by quercetin

Exploring the Spatial Drug Distribution Pattern of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC)

A Microfluidic Perfusion Platform for In Vitro Analysis of Drug Pharmacokinetic-Pharmacodynamic (PK-PD) Relationships

LRP1-mediated pH-sensitive polymersomes facilitate combination therapy of glioblastoma in vitro and in vivo

Ultrasmall nanostructured drug based pH-sensitive liposome for effective treatment of drug-resistant tumor

Bicontinuous Cubic Liquid Crystalline Nanoparticles for Oral Delivery of Doxorubicin: Implications on Bioavailability, Therapeutic Efficacy, and Cardiotoxicity

Pharmacokinetic study of aldoxorubicin in patients with solid tumors

Enhanced Specificity and Drug Delivery in Tumors by cRGD - Anchoring Thermosensitive Liposomes

Distribution of the anticancer drugs doxorubicin, mitoxantrone and topotecan in tumors and normal tissues

Factors affecting the pharmacokinetics of pegylated liposomal doxorubicin in patients

Aktive Filter

Suchergebnisse filtern